In Part I last week, I discussed the Bastos et al. study out of Brazil that found long-term psychodynamic therapy (LTPDT) to have better outcomes than fluoxetine after 24 months of treatment. This week I’ll take a look at another recent study involving another randomized controlled trial (RCT) of LTPDT (called by the authors Long-term Psychoanalytic Psychotherapy or LTPP). In a study out of Britain, Peter Fonagy and colleagues examined the value of LTPDT as a therapy for treatment-resistant depression.

To read the full article, click here